Back to top

Niagen Bioscience selects Evotec to advance development for NB4168

Niagen Bioscience (NAGE) announced that it has selected Evotec (EVO) as a contract research organization to support the advancement of NB4168. The ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Evotec AG (EVO)

Niagen Bioscience, Inc. (NAGE)